Bits of technology from I.B.M.’s Watson are beginning to be used in actual products available to corporate clients. The cloud-based Strategic Intellectual Property Insight Platform “uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical journals to look for chemical compounds used in drug discovery.” As a byproduct of this project, I.B.M. is contributing their research to the searchable NIH chemical database, which will ease access to information previously mired in paperwork.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
TagsBIO biofuels healthcare 2014 BIO International Convention Partnering Benefits of biotech crops BIOTECH Health Care biotechnology Sustainability Plant biotechnology global food crisis Biotechnology Industry BIO Investor Forum BIO International Convention Industry Analysis Food BIO Events climate change health
- Most Popular
Latest VideoLooking Forward to BIO 2015 View All >